Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to HN2008000082ApriorityCriticalpatent/HN2008000082A/es
Publication of HN2008000082ApublicationCriticalpatent/HN2008000082A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA INVENCION TIENE POR OBJETO LOS COMPUESTOS DERIVADOS DE N-(HETEROARIL)-1- HETEROARILALQUIL-1H-INDOL-2-CARBOXAMIDAS, QUE PRESENTAN UNA ACTIVIDAD ANTAGONISTA IN VITRO E IN VIVO PARA LOS RECEPTORES DE TIPO TRPV1 (OVR1)
HN2008000082A2008-01-182008-01-18Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparacion y aplicacion en terapeutica
HN2008000082A
(es)
Compuestos derivados de nucleosidos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que los comprende; y combinacion farmaceutica.